Doxycycline NDC 68308-668

NDC codes

FDA NDC Directory

Product NDC (as listed)68308-668Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68308-0668Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68308-668-30	68308066830	30 CAPSULE in 1 BOTTLE (68308-668-30)Marketed from Feb 27, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline
Generic name (nonproprietary): doxycycline
Active ingredients: Doxycycline — 40 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Mayne Pharma Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 050805
Marketing start: Feb 27, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 68308-668_4600dc6a-950d-4d84-aed9-da01fbd0db8bSPL ID 4600dc6a-950d-4d84-aed9-da01fbd0db8bSPL set ID 0e6b3e17-aeee-4910-8e94-c7ac925b9ccaRxCUI 901399UNII N12000U13O
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468308066830 followed by a unit qualifier and the quantity

Package 68308-0668-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2025.

Indications (excerpt from the label)

Doxycycline is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ( 1.1 ) Limitations of Use This formulation of doxycycline has not been evaluated in the treatment or prevention of infections. Do not use Doxycycline for treating bacterial infections, providing antibacterial prophylaxis, or reducing the numbers or eliminating microorganisms associated with any bacterial disease. ( 1.2 ) Doxycycline has not been evaluated for the treatment of the erythematous, telangiectatic, or ocular components of rosacea. ( 1.2 ) 1.1 Indication Doxycycline is indicated for the treatment of only inflammatory lesions (papule…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050805

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050805
Product	Strength	Form · route	Labeler	Product NDC
Oraceadoxycycline	Doxycycline 40 mg/1	CapsuleOral	Galderma Laboratories, L.P.	0299-3822